270 related articles for article (PubMed ID: 15334182)
1. The inhibition of gamma-secretase as a therapeutic approach to Alzheimer's disease.
Tomita T; Iwatsubo T
Drug News Perspect; 2004 Jun; 17(5):321-5. PubMed ID: 15334182
[TBL] [Abstract][Full Text] [Related]
2. Gamma-secretase inhibitors and Alzheimer's disease.
Roberts SB
Adv Drug Deliv Rev; 2002 Dec; 54(12):1579-88. PubMed ID: 12453675
[TBL] [Abstract][Full Text] [Related]
3. Secretase as a target for Alzheimer's disease.
Wolfe MS
Curr Top Med Chem; 2002 Apr; 2(4):371-83. PubMed ID: 11966461
[TBL] [Abstract][Full Text] [Related]
4. gamma-secretase as a therapeutic target for treatment of Alzheimer's disease.
Tomita T; Iwatsubo T
Curr Pharm Des; 2006; 12(6):661-70. PubMed ID: 16472155
[TBL] [Abstract][Full Text] [Related]
5. Selecting cells with different Alzheimer's disease gamma-secretase activity using FACS. Differential effect on presenilin exon 9 gamma- and epsilon-cleavage.
Sernee MF; Evin G; Culvenor JG; Villadangos JA; Beyreuther K; Masters CL; Cappai R
Eur J Biochem; 2003 Feb; 270(3):495-506. PubMed ID: 12542699
[TBL] [Abstract][Full Text] [Related]
6. APP, Notch, and presenilin: molecular pieces in the puzzle of Alzheimer's disease.
Wolfe MS
Int Immunopharmacol; 2002 Dec; 2(13-14):1919-29. PubMed ID: 12489805
[TBL] [Abstract][Full Text] [Related]
7. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.
Esler WP; Kimberly WT; Ostaszewski BL; Diehl TS; Moore CL; Tsai JY; Rahmati T; Xia W; Selkoe DJ; Wolfe MS
Nat Cell Biol; 2000 Jul; 2(7):428-34. PubMed ID: 10878808
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease. Closing in on gamma-secretase.
De Strooper B
Nature; 2000 Jun; 405(6787):627, 629. PubMed ID: 10864307
[No Abstract] [Full Text] [Related]
9. gamma-Secretase inhibitors as molecular probes of presenilin function.
Wolfe MS
J Mol Neurosci; 2001 Oct; 17(2):199-204. PubMed ID: 11816793
[TBL] [Abstract][Full Text] [Related]
10. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
Pollack SJ; Lewis H
Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
[TBL] [Abstract][Full Text] [Related]
11. Gamma-secretase: substrates and inhibitors.
Rochette MJ; Murphy MP
Mol Neurobiol; 2002 Aug; 26(1):81-95. PubMed ID: 12392058
[TBL] [Abstract][Full Text] [Related]
12. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
13. Role of presenilin in gamma-secretase cleavage of amyloid precursor protein.
Xia W
Exp Gerontol; 2000 Jul; 35(4):453-60. PubMed ID: 10959033
[TBL] [Abstract][Full Text] [Related]
14. Presenilins as therapeutic targets for the treatment of Alzheimer's disease.
Golde TE; Younkin SG
Trends Mol Med; 2001 Jun; 7(6):264-9. PubMed ID: 11378516
[TBL] [Abstract][Full Text] [Related]
15. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.
Li YM; Xu M; Lai MT; Huang Q; Castro JL; DiMuzio-Mower J; Harrison T; Lellis C; Nadin A; Neduvelil JG; Register RB; Sardana MK; Shearman MS; Smith AL; Shi XP; Yin KC; Shafer JA; Gardell SJ
Nature; 2000 Jun; 405(6787):689-94. PubMed ID: 10864326
[TBL] [Abstract][Full Text] [Related]
16. [Targeting the structure and function relationships of the gamma-secretase for the development of Alzheimer's disease].
Tomita T
Rinsho Shinkeigaku; 2008 Nov; 48(11):907-9. PubMed ID: 19198114
[TBL] [Abstract][Full Text] [Related]
17. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.
Wolfe MS; Xia W; Ostaszewski BL; Diehl TS; Kimberly WT; Selkoe DJ
Nature; 1999 Apr; 398(6727):513-7. PubMed ID: 10206644
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
19. Relationship between presenilinase and gamma-secretase.
Xia W
Drug News Perspect; 2003 Mar; 16(2):69-74. PubMed ID: 12792666
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
Evin G; Sernee MF; Masters CL
CNS Drugs; 2006; 20(5):351-72. PubMed ID: 16696577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
